Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
458 Leser
Artikel bewerten:
(2)

Doceree Inc.: Doceree welcomes Karima Sharif as SVP - Strategic Accounts, to strengthen global client partnerships

The industry veteran brings over 25 years of healthcare marketing expertise in accelerating growth and value for leading pharmaceutical brands

LONDON, May 1, 2025 /PRNewswire/ -- Doceree, the world's first global network of physician-only platforms for programmatic messaging, announces the appointment of Karima Sharif as Senior Vice President - Strategic Accounts this April. With over two decades of experience in healthcare media and marketing, Karima joins Doceree to strengthen its strategic partnerships and deliver scalable solutions for pharmaceutical brands and other partners, across its global markets.

Doceree appoints Karima Sharif as AVP-Strategic Accounts

A powerhouse in healthcare marketing, Karima is known as the "Fresh Princess of Media." With an unmatched depth of experience across omnichannel strategy, multicultural and inclusive marketing, customer and data segmentation, and full-funnel media execution across both DTC and HCP audiences, she has helped shape the marketing journeys of 100+ pharmaceutical and medical device brands across various therapeutic categories. Her career is highlighted by the impact she's made at agencies such as CMI/WPP, Publicis and IPG MediaBrands, managing multi-million dollar paid media budgets. At Doceree, Karima will use her experience to drive growth, innovation, and value creation for the company's strategic accounts.

Commenting on her new role, Karima Sharif, SVP - Strategic Accounts, Doceree, said, "I'm thrilled to join Doceree at such a pivotal moment in its journey. The company is truly leading change in the healthcare ecosystem by redefining how pharma marketers engage with HCPs through data-driven, platform-first strategies. I look forward to contributing to this incredible mission and driving meaningful impact alongside a team that's shaping the future of healthcare marketing."

Karima's expertise in building and driving meaningful partnerships, while leading high-performing teams and championing diversity and inclusion conversations in the industry, has earned her accolades like In Vivo's 2022 Rising Leader in Healthcare and DTC Perspectives' 2022 Agency Vanguard Award.

"At Doceree, we are committed to elevating HCP-patient conversations by improving how pharmaceutical brands connect with healthcare professionals in the digital world," said Kamya Elawadhi, Chief Client Officer, Doceree. "Karima's deep expertise in media strategy, inclusive messaging, and full-funnel execution will be pivotal in driving stronger outcomes for our partners and enhancing the overall HCP engagement ecosystem."

Karima is a recognized industry leader, with her thoughts featured in Adweek, MM+M, and more, where she's led important conversations around innovation in healthcare marketing and the need for inclusive, equitable campaigns that resonate with diverse audiences. Her leadership also extends into advocacy, as the cofounder of the Women of Color Affinity Group and former Operating Board President, North America for the Healthcare Businesswomen's Association (HBA), and most recently Sherunsit.org-where she has mentored emerging women leaders.

About Doceree:

Leading the way in making HCP-patient conversations richer and more meaningful through patented responsive technology, Doceree addresses both current and emerging challenges for healthcare and life sciences organizations in HCP-patient engagement, particularly where digital and technological advancements play a crucial role. We leverage our patented technology to ensure that HCP-patient conversations and interactions are more meaningful, richer, and outcome-oriented.

Learn more: www.doceree.com.

Photo: https://mma.prnewswire.com/media/2677835/Karima_Sharif_Doceree.jpg
Logo: https://mma.prnewswire.com/media/1758952/5297442/Doceree_Logo.jpg

Doceree Logo

Cision View original content:https://www.prnewswire.co.uk/news-releases/doceree-welcomes-karima-sharif-as-svp--strategic-accounts-to-strengthen-global-client-partnerships-302443893.html

© 2025 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.